MARKET

CBT

CBT

Cabot
NYSE
93.27
-2.13
-2.23%
After Hours: 93.27 0 0.00% 16:01 04/12 EDT
OPEN
94.59
PREV CLOSE
95.40
HIGH
95.08
LOW
92.74
VOLUME
200.75K
TURNOVER
0
52 WEEK HIGH
98.34
52 WEEK LOW
62.73
MARKET CAP
5.17B
P/E (TTM)
12.10
1D
5D
1M
3M
1Y
5Y
We Think Cabot (NYSE:CBT) Can Stay On Top Of Its Debt
Cabot Corporation (NYSE:CBT) does carry debt. The company had US$1.31b of debt at December 2023. Debt is usually involved in bankruptcies. Cabot's balance sheet shows it has a moderate use of debt. However, its conversion of its EBIT to free cash flow makes us cautious about its debt.
Simply Wall St · 5d ago
Press Release: Cabot Corporation to Announce Second Quarter 2024 Operating Results
Cabot Corporation to announce operating results for the second quarter of fiscal 2024 on May 6, 2024. The Company will host a conference call and live webcast to review the results. Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts.
Dow Jones · 6d ago
Cabot Corporation to Announce Second Quarter 2024 Operating Results
Cabot Corporation will release operating results for the second quarter of fiscal 2024 on May 6, 2024, after market close. The Company will host a conference call and live webcast to review the results on May 7, 2024. Cabot is a global specialty chemicals and performance materials company.
Barchart · 6d ago
Weekly Report: what happened at CBT last week (0401-0405)?
Weekly Report · 6d ago
BioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia
Healthcare BioCorRx receives new patent for novel compound to treat pain, depression, and schizophrenia. The patent is directed towards the use of a compound and composition for treating pain and depression. BioCorrx Pharmaceuticals Inc has been granted a new patent by the U.S. Patent office.
Seeking Alpha · 04/03 12:49
Weekly Report: what happened at CBT last week (0325-0329)?
Weekly Report · 04/01 09:18
Strength Seen in Compass (CMP): Can Its 13.3% Jump Turn into More Strength?
NASDAQ · 03/28 07:42
Orion rated Neutral in new coverage at Mizuho Securities
Orion rated Neutral in new coverage at Mizuho Securities USA. The maker of specialty chemicals and performance materials is fairly valued in proportion to its outlook, analysts say. The company was rated Neutral by Mizuhi Securities USA in new Coverage of Orion S.A. (OEC) Stock.
Seeking Alpha · 03/27 12:47
More
About CBT
Cabot Corporation is a global specialty chemicals and performance materials company. The Company operates through two segments: Reinforcement Materials and Performance Chemicals. The Reinforcement Materials segment combines reinforcing carbons, engineered elastomer composites and EVOLVE Sustainable Solutions product. The reinforcing carbons products are used in tires and industrial products. In Performance Chemicals, it designs, manufacture and sell materials that deliver performance in a range of customer applications across the automotive, construction, infrastructure, inkjet printing, electronics, and consumer products sectors and in applications related to the generation, transmission and storage of energy. The Performance Chemicals segment combine specialty carbons, specialty compounds, battery materials, fumed metal oxides, aerogel and inkjet product lines. Its products include Carbon black, specialty carbons, battery materials, fumed silica, aerogel and inkjet colorants.

Webull offers Cabot Corp stock information, including NYSE: CBT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CBT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CBT stock methods without spending real money on the virtual paper trading platform.